Read here: #cancer #oncology To view or add a comment, sign in 6,856 followers
Current status: Phase 3 trials (expected to continue through 2025-2026) FDA approval timeline: Likely 2026-2027 at the earliest What needs to happen first: Complete Phase 3 trials in larger populations Gather long-term safety data FDA review and approval process Manufacturing scale-up So while the results are exciting, we're still a few years away from retatrutide being available by prescription
The pivotal trials tested 0.25mg as the lowest dose, and even that was considered a non-therapeutic escalation dose
Yang H, Li H, Wang Z, Shi Y, Jiang G, Zeng F
*The above chart is not meant for medical diagnosis purposes
Eligible Programs: Hers/Hims TrimRx Most telehealth GLP-1 providers Manufacturer Savings Programs Brand-name GLP-1 manufacturers offer savings cards that can reduce costs: Wegovy Savings Card: May reduce cost to as low as $0 with commercial insurance Ozempic Savings Card: Up to $150 off per prescription Mounjaro Savings Card: Pay as little as $25 per month with insurance Zepbound Savings Card: Discounts available with commercial insurance Important: These savings programs typically dont work with government insurance (Medicare, Medicaid) or if youre paying cash without insurance
.webp)
